BioCentury
ARTICLE | Company News

Chugai, Taisho Pharmaceutical Holdings, Roche sales and marketing update

May 2, 2016 7:00 AM UTC

Chugai and Taisho launched a monthly oral formulation of Boniva ibandronate in Japan to treat osteoporosis. The National Health Insurance (NHI) price of a 100 mg tablet, the recommended monthly dose,...